Clinical trial / 2016
A nutritional combination with rodent efficacy showed minimal metabolic benefit in human trials.
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
- Study type
- Randomized placebo-controlled trial
- Who was studied
- Healthy volunteers and adults with type 2 diabetes
- What was measured
- Body weight, blood glucose, and HbA1c
THE PAPER
Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes.
Hodge RJ, Paulik MA, Walker A, Boucheron JA, McMullen SL, Gillmor DS, Nunez DJ. PLoS One, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.